March 2017 Issue of MMM
A new survey found that 34% of healthcare and pharma marketers say that the election of President Trump will not affect their marketing budgets.
Despite budgets bouncing back from a decrease in 2015, big threats have appeared that may temper future plans, Iskowitz writes.
Here you'll find everything you need to know from MM&M's March 2017 issue, including our healthcare marketers trend report, our deep dive into orphan drugs, ...
This according to the 172 healthcare marketing executives who participated in the 2017 MM&M/Guidemark Health Healthcare Marketers Trend Report.
Guidemark Health COO Sophy Regelous shares her perspective on the 2017 MM&M/Guidemark Health Healthcare Marketers Report.
There are also issues surrounding privacy and legitimacy. According to one expert's research, very few physicians use social media for professional purposes.
About 30% of patients are more likely to fill a prescription after being exposed to healthcare ads at the point of care, according to Kantar ...
He describes his current charge as "transforming a more creative occupation into a science."
The merger of Quintiles and IMS Health closed in October.
When discussing the nation's ability to stomach orphan drug costs, an analyst has called the price tag "the straw that breaks the camel's back."
Teva Pharmaceutical Industries' Copaxone is by far the top-selling drug, bringing in $3.2 billion in U.S. sales in 2015.
A loaded hemophilia A drug market is an indication patients in and around it are well-served, but that hasn't stopped contenders such as Roche's emicizumab.
Ads promoting Merck's and Bristol-Myers Squibb's immunotherapies could signal the beginning of a new era for DTC.
How can marketers incorporate patient feedback into their marketing strategies without expensive and time-consuming studies?
Last week President Trump told drugmakers that 'the pricing has been astronomical.'
Few questions give healthcare marketers more heart palpitations than this one: "How do you know it will work?"
At the very least, pharma marketers need to make sure they know the difference between search engine marketing and search engine optimization.
Here are six global campaigns that make the case for persuasion.
At Work With
She says her experience in consumer brands helps her push healthcare clients to be more creative.
In our struggle with the bean counters and the stockbrokers, can't we make patient needs a priority, too?
- Five things for pharma marketers to know: Wednesday, March 22, 2017
- Five things for pharma marketers to know: Monday, March 20, 2017
- Novartis aims to bring first oral asthma drug to market in two decades
- Drugmakers target severe asthma patients with biologics, but payers raise pricing issue
- What five different pharma marketing careers look like
- 2017 Healthcare Marketers Trend Report: All the data in one place
- Infographic: What's next for the point of care market
- Drugmakers again boost DTC spending, to $5.6 billion in 2016
- Digital IDs become focus as drugmakers seek to track doctors' behavior online
- Some CME experts remain skeptical when it comes to social media